Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays
HLA · 2026-04 · 107 (4)
DOI: 10.1111/tan.70734 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift HLA, online erschienen am 25.04.2026. Verfasst von Falko M Heinemann und 29 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Essen, Institute for Transfusion Medicine, University Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation, Isoantibodies, HLA Antigens, Histocompatibility Testing. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung Transfusionsmedizin.
Abstract (Originalsprache)
Single antigen (SA) tests are indispensable for an accurate HLA antibody identification in sera of transplant patients. Three commercial tests using purified single antigens combined with microbead or microarray technology are currently available. This study aims to determine the prognostic value of these tests prior to kidney transplantation. Forty‐nine pretransplant sera with donor‐specific antibodies (DSA) from patients who underwent kidney transplantation from a living donor were selected from a previous multicentre study. All sera were tested by a new microspot SA test from BAG and bead array SA assays from Immucor/Werfen (IMM) and One Lambda/ThermoFisher (OLI). AMR‐free survival within 6 months (AMR‐S) and 10‐year death‐censored graft survival (10yGS) were compared to DSA‐negative patients from the original study and evaluated according to (1) number of SA tests classifying the serum as DSA‐positive (DSA+), and (2) number of SA tests detecting at least one identical DSA specificity. In part (1), the 22 patients classified as DSA‐positive by all tests had lowest AMR‐S and 10yGS. OLI was most sensitive and classified all sera as DSA‐positive that were DSA‐positive by BAG and/or IMM. However, the 14 patients who were DSA‐negative by both BAG and IMM, had similar AMR‐S and 10yGS like patients without any DSA. Overall, BAG and IMM had comparable sensitivities. In part (2), at least one identical DSA was detected by all tests in 18 patients, who had worse AMR‐S and 10yGS. In 14 patients, the same DSA was detected by IMM and OLI, or by BAG and OLI, respectively. These patients had lower AMR‐S, but no significant difference in 10yGS. In 17 sera, DSA were detectable by one or more tests, but no specificity was positive in more than one assay (in all sera DSA were detected by OLI, in one additionally another DSA by IMM and in two another DSA by BAG). AMR‐S and 10yGS were similar to DSA‐negative patients. Overall, all three SA assays were suitable for the reliable detection of strong DSA. OLI was shown to be the most sensitive assay, but also prone to possible false positive results defined by the lack of an association with impaired outcomes. Future studies are needed to determine how many OLI‐only reactions are caused by very weak DSA and how many by reactions with denatured beads. While such reactions were rare for BAG and IMM assays, these tests missed some DSA associated with an increased risk for AMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Hospital Essen, Institute for Transfusion Medicine, University Duisburg-Essen, Essen, Germany.
- Hannover Medical School, Institute of Transfusion Medicine and Transplant Engineering, Hannover, Germany.
- University Hospital of Tuebingen, Institute for Clinical and Experimental Transfusion Medicine, Tübingen, Germany.
- Charité-Universitätsmedizin Berlin, Medizinische Klinik m. S. Nephrologie, Berlin, Germany.
- Universitätsmedizin Göttingen, Klinik für Nephrologie und Rheumatologie, Göttingen, Germany.
- Knappschaftskrankenhaus Bottrop, Klinik für Innere Medizin II - Nephrologie und Rheumatologie, Bottrop, Germany.
ORCID-Profile: Martina Koch, Nils Lachmann, Daniel Zecher, Malte Ziemann
Förderung
- Stiftung Transfusionsmedizin
Zitieren
APA
Heinemann, F. M., Hallensleben, M., Althaus, K., Budde, K., Einecke, G., Eisenberger, U., Ender, A., Feldkamp, T., Grahammer, F., Guthoff, M., Holzmann-Littig, C., Hugo, C., Kauke, T., Kemmner, S., Koch, M., Lachmann, N., Lindemann, M., Morath, C., Nitschke, M., …, & Ziemann, M. (2026). Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays. HLA, 107(4). https://doi.org/10.1111/tan.70734
Vancouver
Heinemann FM, Hallensleben M, Althaus K, Budde K, Einecke G, Eisenberger U, et al. Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays. HLA. 2026;107(4). doi:10.1111/tan.70734
BibTeX
@article{Heinemann2026,
author = {Heinemann, Falko M and Hallensleben, Michael and Althaus, Karina and Budde, Klemens and Einecke, Gunilla and Eisenberger, Ute and Ender, Andrea and Feldkamp, Thorsten and Grahammer, Florian and Guthoff, Martina and Holzmann-Littig, Christopher and Hugo, Christian and Kauke, Teresa and Kemmner, Stephan and Koch, Martina and Lachmann, Nils and Lindemann, Monika and Morath, Christian and Nitschke, Martin and Renders, Lutz and Scherer, Sabine and Schlaf, Gerald and Stumpf, Julian and Schwenger, Vedat and Sommer, Florian and Spriewald, Bernd M and Süsal, Caner and Verboom, Murielle and Zecher, Daniel and Ziemann, Malte},
title = {Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays},
journal = {HLA},
year = {2026},
volume = {107},
number = {4},
doi = {10.1111/tan.70734}
}
EUVIMED